Ibnsina Pharma

ISPH

EGS512O1C012

Drug Retailers

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
2.37 ^EGP	+5.80%		-2.07%	-24.52%

Mar. 03	Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 05	Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index	CI

Ibnsina Pharma Appoints Mohamed Mohsen Mohamed Mahgoub as CEO

April 04, 2021 at 01:52 pm EDT

Ibnsina Pharma appointed Mohamed Mohsen Mohamed Mahgoub as CEO.

Latest news about Ibnsina Pharma

Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 03	CI
Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index	Feb. 04	CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-13	CI
Ibnsina Pharma(CASE:ISPH) dropped from EGX 30 Index	23-08-02	CI
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-23	CI
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01	CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Ibnsina Pharma(CASE:ISPH) dropped from S&P Global BMI Index	22-09-19	CI
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-14	CI
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-22	CI
Ibn Sina Pharma Company (S.A.E) acquired El Shorouk Hospital for EGP 430 million.	22-05-21	CI
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-23	CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-14	CI
Ibn Sina Pharma Company (S.A.E.) Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021	21-08-15	CI
Ibnsina Pharma Reports Consolidated and Standalone Earnings Results for the First Quarter of 2021	21-05-31	CI
Ibnsina Pharma Announces Board Changes	21-04-04	CI
Ibnsina Pharma Appoints Mohamed Mohsen Mohamed Mahgoub as CEO	21-04-04	CI
Ibnsina Pharma Reports Earnings Results for the Full Year 2020	21-04-04	CI
Ibn Sina Pharma (S.A.E) Announces Audited Standalone Earnings Results for the Full Year Ended December 31, 2020	21-02-28	CI
Ibn Sina Pharma (S.A.E) completed the acquisition of 75% stake in 3elagi Tech.	20-11-12	CI
Ibn Sina Pharma (S.A.E) signed an agreement to acquire 75% stake in 3elagi Tech.	20-11-08	CI
Ibnsina Pharma Reports Earnings Results for the First Quarter of 2020	20-06-09	CI
Ibn Sina Pharma (S.A.E)(CASE:ISPH) added to EGX 30 Index	19-08-01	CI
Ibnsina Pharma Announces Earnings Results for the Three Months Ended March 31, 2019	19-05-11	CI

Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.

Sector

Drug Retailers

More about the company

Income Statement Evolution

More financial data

Ratings for Ibnsina Pharma

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.37 EGP

Average target price

4.632 EGP

Spread / Average Target

+95.46%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
IBNSINA PHARMA	-24.52%	50.93M
WALGREENS BOOTS ALLIANCE, INC.	-30.37%	15.82B
JD HEALTH INTERNATIONAL INC.	-22.51%	12.65B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-22.88%	6.6B
YIFENG PHARMACY CHAIN CO., LTD.	+11.76%	6.3B
MATSUKIYOCOCOKARA & CO.	-6.01%	6.11B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+64.02%	4.75B
NAHDI MEDICAL COMPANY	-1.17%	4.69B
CLICKS GROUP LIMITED	-5.58%	4.02B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-7.87%	3.59B

Other Drug Retailers

Ibnsina Pharma

Equities

ISPH

EGS512O1C012

Drug Retailers

Ibnsina Pharma Appoints Mohamed Mohsen Mohamed Mahgoub as CEO

Latest news about Ibnsina Pharma

Chart Ibnsina Pharma

Company Profile

Income Statement Evolution

Ratings for Ibnsina Pharma

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Drug Retailers